Follow us on:
Breaking News
April 8, 2026
Breaking News
Breaking News

Flexibility in Drug Development: From Tactical Response to Strategic Discipline

 
Flexibility in Drug Development: From Tactical Response to Strategic Discipline

How strategic flexibility enables continuity, scalability, and reliable execution in modern drug development.
Read More >>

Headlines

Breaking News

Gilead Sciences Agrees to Acquire Tubulis

The acquisition expands Gilead’s ADC capabilities by adding next-generation assets and platforms.

SPONSOR

Strengthen your early phase clinical trials strategy

Gain data-driven insights to accelerate early phase clinical trials and support smarter, more confident decisions across your R&D pipeline. LEARN MORE

Breaking News
Collaborations & Alliances

Halozyme, Vertex Pharmaceuticals Enter Exclusive Collab & License Agreement

Vertex licenses Halozyme's Hypercon technology for use in up to three drug targets.

Breaking News
Collaborations & Alliances

AC Immune, Lilly Amend Morphomer Tau Alliance

IND-enabling studies to begin in 1H26 for potential treatment of Alzheimer’s and other neurodegenerative diseases.

SPONSOR

[LIVE EVENT] Enhancing Bioprocess Productivity through Modern Machine Learning Methods

In this webinar on April 15, learn how modern ML improves bioprocess productivity. Seongjin Kim of Samsung Biologics shows how XGBoost, Bayesian optimization, and explainable AI identify key process variables and drive data-driven performance gains.

Allos_Enl_040826_650x250

Breaking News

Allucent Expands Specialty CRO Focus Across Oncology, Neuro, CGT 

New roles to support emerging biopharma innovation across complex therapeutic areas and advanced modalities.

Breaking News

Vion Biosciences Acquires Cellular Technology Limited

Adds analyzers, software, consumables and services at a workflow-critical measurement layer across translational and clinical research.

Featured Resources

Solution Center SPOTLIGHT

Lannett CDMO

Lannett CDMO is a US-based contract manufacturing organization with decades of pharmaceutical experience. We specialize in oral solid dose and non-injectable liquid manufacturing, high-potency compounds, and controlled substances. Our comprehensive services include advanced analytics, regulatory support, and supply chain management.

 

Solution Center SPOTLIGHT

MG America

MG America is a recognized leader in supplying today’s finest European-crafted packaging and processing machinery to leading pharmaceutical, nutritional, OTC and medical device companies located throughout the United States, Canada and Puerto Rico. The company takes tremendous pride in the relationships that it builds with its customers.